Concentrix Corporation
CNXC
$46.92
-$0.53-1.12%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.66% | 35.20% | 44.09% | 33.62% | 22.67% |
| Total Other Revenue | -- | -64.61% | -25.23% | -0.74% | 24.58% |
| Total Revenue | 21.66% | 35.20% | 44.09% | 33.62% | 22.67% |
| Cost of Revenue | 22.12% | 36.00% | 43.68% | 32.93% | 21.90% |
| Gross Profit | 20.85% | 33.78% | 44.83% | 34.85% | 24.04% |
| SG&A Expenses | 17.83% | 37.25% | 63.96% | 48.09% | 30.65% |
| Depreciation & Amortization | 113.62% | 113.62% | 32.06% | 32.06% | 32.06% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.74% | 38.93% | 48.51% | 36.74% | 24.40% |
| Operating Income | 1.73% | 2.45% | 7.73% | 7.82% | 8.19% |
| Income Before Tax | -9.78% | -26.69% | -46.63% | -35.87% | -37.11% |
| Income Tax Expenses | -31.62% | -49.08% | -59.54% | -50.58% | -48.33% |
| Earnings from Continuing Operations | -3.13% | -19.95% | -41.30% | -29.76% | -32.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.13% | -19.95% | -41.30% | -29.68% | -32.61% |
| EBIT | 1.73% | 2.45% | 7.73% | 7.82% | 8.19% |
| EBITDA | 16.19% | 30.04% | 42.83% | 33.35% | 23.83% |
| EPS Basic | -17.75% | -35.72% | -54.00% | -40.39% | -38.58% |
| Normalized Basic EPS | -17.24% | -31.56% | -48.27% | -36.12% | -28.92% |
| EPS Diluted | -17.57% | -35.53% | -53.83% | -40.14% | -38.31% |
| Normalized Diluted EPS | -17.06% | -31.37% | -48.07% | -35.85% | -28.62% |
| Average Basic Shares Outstanding | 12.42% | 20.76% | 25.94% | 19.21% | 12.11% |
| Average Diluted Shares Outstanding | 12.22% | 20.46% | 25.48% | 18.70% | 11.60% |
| Dividend Per Share | 10.01% | 10.00% | 10.00% | 10.00% | 10.00% |
| Payout Ratio | 0.27% | 0.65% | 1.44% | 0.93% | 0.90% |